Friedman, H. S., Herndon, J. E., McSherry, F., Ravelo, A., Lipp, E. S., Healy, P., … Desjardins, A. (2014). Single-institution retrospective review of newly diagnosed glioblastoma (GBM) patients (pts) treated on bevacizumab (BEV) in clinical practice. In Journal of Clinical Oncology (Vol. 32, pp. 2082–2082). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2014.32.15_suppl.2082

Friedman, Henry S., James Emmett Herndon, Frances McSherry, Arliene Ravelo, Eric S. Lipp, Patrick Healy, Katherine B. Peters, et al. “Single-institution retrospective review of newly diagnosed glioblastoma (GBM) patients (pts) treated on bevacizumab (BEV) in clinical practice.” In Journal of Clinical Oncology, 32:2082–2082. American Society of Clinical Oncology (ASCO), 2014. https://doi.org/10.1200/jco.2014.32.15_suppl.2082.

Friedman HS, Herndon JE, McSherry F, Ravelo A, Lipp ES, Healy P, et al. Single-institution retrospective review of newly diagnosed glioblastoma (GBM) patients (pts) treated on bevacizumab (BEV) in clinical practice. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 2082–2082.

Friedman, Henry S., et al. “Single-institution retrospective review of newly diagnosed glioblastoma (GBM) patients (pts) treated on bevacizumab (BEV) in clinical practice.” Journal of Clinical Oncology, vol. 32, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2014, pp. 2082–2082. Crossref, doi:10.1200/jco.2014.32.15_suppl.2082.

Friedman HS, Herndon JE, McSherry F, Ravelo A, Lipp ES, Healy P, Peters KB, Ranjan T, Vlahovic G, Watts J, Sampson JH, Friedman AH, Desjardins A. Single-institution retrospective review of newly diagnosed glioblastoma (GBM) patients (pts) treated on bevacizumab (BEV) in clinical practice. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2014. p. 2082–2082.